UPDATE : Friday, May 17, 2019
상단여백
‘Bladder cancer treatment OncoTICE not out of stock’
The Ministry of Food and Drug Safety urgently notified that OncoTICE inject...
by Lee Hye-seon  |  2019-03-19 14:44
라인
Il-yang, Hanmi achieve robust sales growth in China
Two Korean pharmaceutical firms -- Il-yang Pharmaceutical and Hanmi Pharmac...
by Jeong Sae-im  |  2019-03-19 11:21
라인
Macrogen, Microba to cooperate on microbiome research
Macrogen said Monday that it has signed a memorandum of understanding with ...
by Lee Han-soo  |  2019-03-19 11:14
라인
Daewoong wins right to sell TerahVax’s typhoid fever vaccine
Daewoong Pharmaceutical said Tuesday that it plans to launch TerahVax Korea...
by Lee Han-soo  |  2019-03-19 11:14
라인
Hanmi, Santen sign co-promotion accord for dry eye treatments
Hanmi Pharmaceutical said Monday that it has signed a co-promotion agreemen...
by Lee Han-soo  |  2019-03-18 17:46
라인
Dong-A ST to market Suganon in India
Dong-A ST said Monday that it would start marketing Suganon, an independent...
by Lee Han-soo  |  2019-03-18 15:03
라인
Merz’ check against Medytox: ‘Xeomin is the only pure toxin’
Apparently mindful of a rival botulinum toxin scheduled to be released in t...
by Jeong Sae-im  |  2019-03-18 15:03
라인
Hanmi’s US partner yanks BLA application for Rolontis after FDA demands more data
Spectrum, Hanmi Pharmaceutical’s U.S. partner, said Friday that it has resc...
by Lee Han-soo  |  2019-03-18 14:23
라인
Reimbursement for orphan drug Spinraza imminent
Biogen’s Spinraza (ingredient: nusinersen), a treatment for spinal muscular...
by Kim Yun-mi  |  2019-03-18 12:02
라인
Handok gets shares in TRIGR Therapeutics
Handok said Monday that it has invested $5 million to acquire shares in TRI...
by Lee Han-soo  |  2019-03-18 12:02
라인
Korean patients lack knowledge about risk of resistance development by BTX
More than half of the people who have undergone botulinum toxin (BTX) treat...
by Lee Han-soo  |  2019-03-15 15:39
라인
Dong-A ST slapped with ₩13.8 billion penalty for bribing doctors
The Ministry of Health and Welfare has ordered the suspension of reimbursem...
by Kwak Sung-sun  |  2019-03-15 15:38
라인
Theragen’s Lou Gehrig's disease treatment wins government support
Theragen ETEX said Friday that the Korea Drug Development Fund (KDDF) would...
by Lee Han-soo  |  2019-03-15 13:21
라인
SK Chemicals executive arrested for destroying evidence in humidifier sterilizers case
A high-ranking official at SK Chemicals has been arrested for trying to cov...
by Jeong Sae-im  |  2019-03-15 11:41
라인
Pharmbio Korea to develop antifungal drug with BioSynectics’ nanotechnology
Pharmbio Korea said Wednesday that it has signed a licensing-in deal with B...
by Lee Han-soo  |  2019-03-13 17:48
라인
Daewoong to enter P3 trial for Nabota in China
Daewoong Pharmaceutical said Wednesday that the China Food and Drug Adminis...
by Lee Han-soo  |  2019-03-13 15:43
라인
Regulator OKs Yuyu’s P2 clinical trial into dry eye treatment
Yuyu Pharmaceutical said Wednesday that the Ministry of Food and Drug Safet...
by Lee Han-soo  |  2019-03-13 12:43
라인
Tecentriq becomes 1st immunotherapy OKed for specific breast cancer
Roche said its PD-L1 (programmed death-ligand 1) inhibitor Tecentriq (ingre...
by Kim Yun-mi  |  2019-03-13 12:43
라인
GemVax & KAEL completes patient enrollment for P2 clinical trial into GV1001
GemVax & KAEL said Wednesday that it has completed patient registration for...
by Lee Han-soo  |  2019-03-13 10:49
라인
Dong-A ST’s erectile dysfunction treatment improves postmicturition dribbling
Dong-A ST said Monday that it has confirmed that Zydena (ingredient: Udenaf...
by Lee Han-soo  |  2019-03-12 18:02
여백
여백
여백
Back to Top